SMARCB1 and rhabdoid tumor: Loss of SMARCB1 expression has been reported to be associated with atypical teratoid / rhabdoid tumors (AT / RT) and malignant rhabdoid tumors (MRTs) of the kidney and extrarenal tissues [2].